Celularity Inc. (CELU) vs Eloxx Pharmaceuticals, Inc. (ELOX)

A side-by-side comparison of Celularity Inc. and Eloxx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CELU

Celularity Inc.

$46M

$1.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

ELOX

Eloxx Pharmaceuticals, Inc.

$52M

$15.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CELU vs ELOX

growth of $100 · dividends reinvested · last 1y

CELU +110.6% (+110.6%/yr)ELOX +40.0% (+40.0%/yr)CELU compounded faster over this window

CELU ELOX

Metrics side by side

Total return (annualized)

Metric	CELU	ELOX
Total return (1Y)	-19.63%	N/A
Total return CAGR (3Y)	-6.77%	N/A
Total return CAGR (5Y)	-52.57%	N/A

ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CELU analysis Full ELOX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.